Signal transduction interception as a novel approach to disease management.
D000818:Animals; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use / Q000633:toxicity; D000970:Antineoplastic Agents / Q000627:therapeutic use / Q000633:toxicity; D001161:Arteriosclerosis / Q000517:prevention & control; D015195:Drug Design; D004791:Enzyme Inhibitors / Q000627:therapeutic use* / Q000633:toxicity; D006801:Humans; D009389:Neovascularization, Pathologic / Q000517:prevention & control; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*; D012008:Recurrence; D015398:Signal Transduction; D013812:Therapeutics
D000894:Anti-Inflammatory Agents, Non-Steroidal; D000970:Antineoplastic Agents; D004791:Enzyme Inhibitors; D011505:Protein-Tyrosine Kinases